Hudson Bay Capital Management Portfolio holdings
AUM
$15.2B
1-Year Return
11.47%
This Quarter Return
+2.77%
1 Year Return
+11.47%
3 Year Return
+62.45%
5 Year Return
+105.91%
10 Year Return
+214.7%
AUM
$16.6B
AUM Growth
+$2.06B
(+14%)
Cap. Flow
-$860M
Cap. Flow
% of AUM
-5.19%
Top 10 Holdings %
Top 10 Hldgs %
30.4%
Holding
951
New
253
Increased
184
Reduced
160
Closed
190
Top Buys
| 1 |
Tesla
TSLA
|
$224M |
| 2 |
UnitedHealth
UNH
|
$223M |
| 3 |
Strategy Inc Common Stock Class A
MSTR
|
$156M |
| 4 |
Arm
ARM
|
$148M |
| 5 |
Eli Lilly
LLY
|
$145M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$608M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$297M |
| 3 |
NVIDIA
NVDA
|
$285M |
| 4 |
Broadcom
AVGO
|
$275M |
| 5 |
Invesco QQQ Trust
QQQ
|
$211M |
Sector Composition
| 1 | Technology | 27.98% |
| 2 | Consumer Discretionary | 11.16% |
| 3 | Financials | 10.96% |
| 4 | Healthcare | 7.38% |
| 5 | Real Estate | 4.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Biohaven
BHVN
$1.68B
| $1.6M | 0.01% |
42,931
+30,431
| +243% | +$1.14M |
|
|
QXO
502
QXO Inc
QXO
$14.9B
| $1.6M | 0.01% |
100,697
+10,697
| +12% | +$170K |
|
503
General Mills
GIS
$27B
| $1.53M | 0.01% |
24,063
+5,048
| +27% | +$322K |
|
504
Elanco Animal Health
ELAN
$9.16B
| $1.51M | 0.01% |
125,000
+25,000
| +25% | +$303K |
|
505
CoStar Group
CSGP
$37.9B
| $1.49M | 0.01% |
+20,878
| New | +$1.49M |
|
|
CITE
506
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
| $1.48M | 0.01% |
+125,000
| New | +$1.48M |
|
507
Baker Hughes
BKR
$44.9B
| $1.44M | 0.01% |
+35,058
| New | +$1.44M |
|
508
Rocket Pharmaceuticals
RCKT
$354M
| $1.43M | 0.01% |
113,500
+48,500
| +75% | +$610K |
|
|
LATG
509
DELISTED
Chenghe Acquisition I Co. Class A Ordinary Shares
LATG
| $1.39M | ﹤0.01% |
+154,000
| New | +$1.39M |
|
510
Four Leaf Acquisition Corp
FORL
| $1.39M | ﹤0.01% |
125,000
| – | – |
|
|
ONC
511
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $1.39M | ﹤0.01% |
7,500
+2,500
| +50% | +$462K |
|
512
Bowen Acquisition Corp
BOWN
| $1.37M | ﹤0.01% |
125,000
| – | – |
|
513
Marathon Digital Holdings
MARA
$5.63B
| $1.34M | ﹤0.01% |
+80,000
| New | +$1.34M |
|
|
SAGE
514
DELISTED
Sage Therapeutics
SAGE
| $1.34M | ﹤0.01% |
247,000
-98,000
| -28% | -$532K |
|
515
Planet Fitness
PLNT
$8.77B
| $1.32M | ﹤0.01% |
+13,339
| New | +$1.32M |
|
|
RVNC
516
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.26M | ﹤0.01% |
414,310
+264,310
| +176% | +$804K |
|
517
Acumen Pharmaceuticals
ABOS
$87.2M
| $1.23M | ﹤0.01% |
715,000
+79,000
| +12% | +$136K |
|
518
Oak Woods Acquisition Corp
OAKU
| $1.19M | ﹤0.01% |
105,000
| – | – |
|
519
Aviat Networks
AVNW
$285M
| $1.18M | ﹤0.01% |
+65,423
| New | +$1.18M |
|
520
Maravai LifeSciences
MRVI
$363M
| $1.17M | ﹤0.01% |
215,243
+87,846
| +69% | +$479K |
|
521
Brinker International
EAT
$7.04B
| $1.17M | ﹤0.01% |
+8,809
| New | +$1.17M |
|
522
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $1.15M | ﹤0.01% |
835,000
+50,000
| +6% | +$69K |
|
523
CF Industries
CF
$13.7B
| $1.14M | ﹤0.01% |
13,390
-31,610
| -70% | -$2.7M |
|
524
Celldex Therapeutics
CLDX
$1.52B
| $1.14M | ﹤0.01% |
+45,000
| New | +$1.14M |
|
525
Atlanticus Holdings
ATLC
$1.03B
| $1.12M | ﹤0.01% |
+20,052
| New | +$1.12M |
|